Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Toxicologic Pathology|February 27, 2018
Circulating liver-specific microRNAs in cynomolgus monkeysTakuma Iguchi, Ken Sakurai, Satoshi Tamai, et al.Chemical & Pharmaceutical Bulletin|November 2, 2006
Efficient synthesis of isothiocyanates based on the tandem Staudinger/aza-Wittig reactions and mechanistic consideration of the tandem reactionsTakeshi Isoda, Kazuhiko Hayashi, Satoshi Tamai, et al.Journal of Visualized Experiments : Jove|March 20, 2018
Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCRTakuma Iguchi, Noriyo Niino, Satoshi Tamai, et al.Chemical & Pharmaceutical Bulletin|October 4, 2006
A practical and facile synthesis of azetidine derivatives for oral carbapenem, L-084Takeshi Isoda, Itsuki Yamamura, Satoshi Tamai, et al.International Journal of Toxicology|May 3, 2017
Comprehensive Analysis of Circulating microRNA Specific to the Liver, Heart, and Skeletal Muscle of Cynomolgus MonkeysTakuma Iguchi, Noriyo Niino, Satoshi Tamai, et al.Antibiotics (Basel, Switzerland)|December 24, 2021
Isolation of Human Lineage, Fluoroquinolone-Resistant and Extended-β-Lactamase-Producing <i>Escherichia coli</i> Isolates from Companion Animals in JapanToyotaka Sato, Shin-Ichi Yokota, Tooru Tachibana, et al.The Journal of Toxicological Sciences|January 11, 2017
A monkey model of acetaminophen-induced hepatotoxicity; phenotypic similarity to humanSatoshi Tamai, Takuma Iguchi, Noriyo Niino, et al.The Journal of Veterinary Medical Science|September 17, 2025
Prevalence, antimicrobial susceptibility, and virulence profiles of fluoroquinolone-resistant Escherichia coli isolated from companion animals in Sapporo, JapanAiko Maeda, Toyotaka Sato, Jirachaya Toyting-Hiraishi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Gallbladder carcinoma, progressed along cholecystoduodenal fistula--a case report]Takahiro Sanada, Hiroyuki Baba, Atsushi Ohba, et al.Human Vaccines & Immunotherapeutics|November 27, 2014
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trialMasanari Shiramoto, Shin Irie, Christine Juergens, et al.Pageof 2